Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Free Cash Flow (2017 - 2025)

Catheter Precision (VTAK) has disclosed Free Cash Flow for 9 consecutive years, with -$1.5 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 47.07% to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.3 million through Dec 2025, up 10.93% year-over-year, with the annual reading at -$8.3 million for FY2025, 10.93% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$1.5 million at Catheter Precision, up from -$2.2 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$1.5 million in Q4 2025, with the low at -$12.1 million in Q1 2023.
  • Average Free Cash Flow over 5 years is -$4.4 million, with a median of -$3.0 million recorded in 2022.
  • Peak annual rise in Free Cash Flow hit 83.94% in 2024, while the deepest fall reached 51.17% in 2024.
  • Over 5 years, Free Cash Flow stood at -$5.9 million in 2021, then soared by 48.87% to -$3.0 million in 2022, then skyrocketed by 37.31% to -$1.9 million in 2023, then crashed by 50.18% to -$2.9 million in 2024, then skyrocketed by 47.07% to -$1.5 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$1.5 million, -$2.2 million, and -$2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.